Your Complete Guide to Global Clinical Research and GCP Compliance
Data Quality and Reconciliation Controls for Robust SAE Intake, Documentation & Timelines Data Quality and Reconciliation Controls for Robust SAE Intake, Documentation & Timelines In the landscape of clinical trials, the accurate and timely handling of Serious Adverse Events (SAEs) is paramount. This article provides a comprehensive step-by-step tutorial for clinical operations, regulatory affairs, and…
SUSAR Detection & Expedited Reporting in Practice: Step-by-Step Guide for Sponsors and CROs SUSAR Detection & Expedited Reporting in Practice: Step-by-Step Guide for Sponsors and CROs Introduction to SUSARs in Clinical Trials Safety monitoring in clinical trials is paramount, especially when it involves vulnerable patient populations, such as those undergoing treatment for non-small cell lung…
SUSAR Detection & Expedited Reporting: End-to-End Compliance Framework for Global Clinical Trials SUSAR Detection & Expedited Reporting: End-to-End Compliance Framework for Global Clinical Trials Introduction to SUSAR in Clinical Trials Serious Unexpected Suspected Adverse Reactions (SUSARs) play a critical role in ensuring patient safety during clinical trials. The detection and expedited reporting of SUSARs are…
Digital Tools and Automation to Streamline SUSAR Detection & Expedited Reporting Digital Tools and Automation to Streamline SUSAR Detection & Expedited Reporting In the landscape of clinical research, the identification and reporting of Serious Unexpected Suspected Adverse Reactions (SUSARs) is critical to ensuring participant safety and maintaining compliance with regulatory guidelines. This article provides a…
Read More “Digital Tools and Automation to Streamline SUSAR Detection & Expedited Reporting” »
Aligning SUSAR Detection & Expedited Reporting With GCP, ICH E2A–E2F and Local Regulations Aligning SUSAR Detection & Expedited Reporting With GCP, ICH E2A–E2F and Local Regulations In the complex landscape of clinical trials, the detection and reporting of Suspected Unexpected Serious Adverse Reactions (SUSARs) are critical components that must align with regulatory frameworks such as…
Common Pitfalls in SUSAR Detection & Expedited Reporting—and How to Avoid Regulatory Findings Common Pitfalls in SUSAR Detection & Expedited Reporting—and How to Avoid Regulatory Findings In the highly regulated environment of clinical research, the accurate detection and expedited reporting of Suspected Unexpected Serious Adverse Reactions (SUSARs) are critical components of ensuring patient safety, maintaining…
Case Studies: SUSAR Detection & Expedited Reporting That Strengthened Safety Oversight Case Studies: SUSAR Detection & Expedited Reporting That Strengthened Safety Oversight In the realm of clinical trials, the detection and expedited reporting of Suspected Unexpected Serious Adverse Reactions (SUSARs) is paramount to ensuring participant safety and regulatory compliance. This article serves as a tutorial…
Read More “Case Studies: SUSAR Detection & Expedited Reporting That Strengthened Safety Oversight” »
KRIs, KPIs and Dashboards to Monitor SUSAR Detection & Expedited Reporting Across Portfolios KRIs, KPIs and Dashboards to Monitor SUSAR Detection & Expedited Reporting Across Portfolios The monitoring of Serious Unexpected Suspected Adverse Reactions (SUSARs) is essential in clinical trials to ensure patient safety and regulatory compliance. In this step-by-step tutorial, we will delve into…
Inspection-Ready Documentation Standards for SUSAR Detection & Expedited Reporting Inspection-Ready Documentation Standards for SUSAR Detection & Expedited Reporting In today’s complex landscape of clinical research, the accurate and timely reporting of Suspected Unexpected Serious Adverse Reactions (SUSARs) is of paramount importance. Regulatory bodies like the FDA, EMA, and MHRA require comprehensive documentation standards to ensure…
Read More “Inspection-Ready Documentation Standards for SUSAR Detection & Expedited Reporting” »
Training Investigators and Sites to Execute SUSAR Detection & Expedited Reporting Reliably Training Investigators and Sites to Execute SUSAR Detection & Expedited Reporting Reliably In the context of clinical trials, recognizing and reporting Serious Unexpected Serious Adverse Reactions (SUSARs) is a critical component of patient safety and regulatory compliance. This detailed guide aims to equip…